OBJECTIVE: To detect immunoglobulin M (IgM) anti-Toxoplasma gondii antibodies and determine immunoglobulin G (IgG) titer and avidity in filter paper-embedded blood (FPEB) samples of pregnant women. STUDY DESIGN: A total of 100 FPEB samples of pregnant women (30 positive and 70 negative) were analyzed for anti-T. gondii-specific IgM antibodies. Eleven and nine pairs of serum and FPEB samples were used to standardize IgG titration and avidity, respectively. Then, the correlation of avidity results was determined with 23 serum/FPEB pairs from IgG-positive cases. RESULT: IgM detection in FPEB was 92% sensitive and 100% specific. The titration of IgG antibodies in FPEB correlated with that of serum (r >or=0.9). Significant difference in avidity between the acute and the undetermined/chronic cases was observed in both samples. As expected, no correlation was found between IgM levels and avidity. CONCLUSION: The FPEB is useful to infer infection phase, and thus to speed clinical decisions in congenital toxoplasmosis management.
OBJECTIVE: To detect immunoglobulin M (IgM) anti-Toxoplasma gondii antibodies and determine immunoglobulin G (IgG) titer and avidity in filter paper-embedded blood (FPEB) samples of pregnant women. STUDY DESIGN: A total of 100 FPEB samples of pregnant women (30 positive and 70 negative) were analyzed for anti-T. gondii-specific IgM antibodies. Eleven and nine pairs of serum and FPEB samples were used to standardize IgG titration and avidity, respectively. Then, the correlation of avidity results was determined with 23 serum/FPEB pairs from IgG-positive cases. RESULT: IgM detection in FPEB was 92% sensitive and 100% specific. The titration of IgG antibodies in FPEB correlated with that of serum (r >or=0.9). Significant difference in avidity between the acute and the undetermined/chronic cases was observed in both samples. As expected, no correlation was found between IgM levels and avidity. CONCLUSION: The FPEB is useful to infer infection phase, and thus to speed clinical decisions in congenital toxoplasmosis management.
Authors: Yagahira E Castro-Sesquen; Freddy Tinajeros; Caryn Bern; Gerson Galdos-Cardenas; Edith S Malaga; Edward Valencia Ayala; Kathryn Hjerrild; Steven J Clipman; Andrés G Lescano; Tabitha Bayangos; Walter Castillo; María Carmen Menduiña; Kawsar R Talaat; Robert H Gilman Journal: Clin Infect Dis Date: 2021-07-15 Impact factor: 9.079
Authors: Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans Journal: Clin Microbiol Rev Date: 2019-12-11 Impact factor: 26.132
Authors: Monica Goldberg-Murow; Carlos Cedillo-Peláez; Luz Elena Concha-Del-Río; Rashel Cheja-Kalb; María José Salgar-Henao; Eduardo Orozco-Velasco; Héctor Luna-Pastén; Fernando Gómez-Chávez; Antonio Ibarra; Dolores Correa Journal: Front Immunol Date: 2021-05-12 Impact factor: 7.561
Authors: Ivonne Hernández-Cortazar; Karla Y Acosta-Viana; Antonio Ortega-Pacheco; Eugenia del S Guzman-Marin; Armando J Aguilar-Caballero; Matilde Jiménez-Coello Journal: Rev Inst Med Trop Sao Paulo Date: 2015 Mar-Apr Impact factor: 1.846
Authors: Fernando Gómez-Chávez; Irma Cañedo-Solares; Luz Belinda Ortiz-Alegría; Yevel Flores-García; Ricardo Figueroa-Damián; Héctor Luna-Pastén; Valeria Gómez-Toscano; Carlos López-Candiani; G Emmanuel Arce-Estrada; Christian A Bonilla-Ríos; Juan Carlos Mora-González; Ricardo García-Ruiz; Dolores Correa Journal: Front Immunol Date: 2020-03-13 Impact factor: 7.561